Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor

被引:139
|
作者
Couturier, Aude [1 ]
Rey, Pierre-Antoine [1 ]
Erginay, Ali [1 ]
Lavia, Carlo [1 ]
Bonnin, Sophie [1 ]
Dupas, Benedicte [1 ]
Gaudric, Alain [1 ]
Tadayoni, Ramin [1 ]
机构
[1] Univ Paris 07, Lariboisiere Hosp, AP HP, Dept Ophthalmol,Sorbonne Paris Cite, Paris, France
关键词
PROGRESSIVE RETINAL NONPERFUSION; MACULAR EDEMA; PANRETINAL PHOTOCOAGULATION; VEIN OCCLUSION; RANIBIZUMAB; REPERFUSION; EYES;
D O I
10.1016/j.ophtha.2019.06.022
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To assess change in retinal nonperfusion (NP) after anti-vascular endothelial growth factor (VEGF) therapy for diabetic macular edema (DME) using 2 different imaging modalities: swept-source widefield (SS-WF) OCT angiography (OCTA) and ultra-widefield (UWF) fluorescein angiography (FA). Design: Observational case series. Participants: Ten eyes of 9 patients with severe nonproliferative diabetic retinopathy (NPDR) or proliferative DR (PDR) initiating 3 monthly anti-VEGF intravitreal injections for DME. Methods: All eyes were imaged with UWF color fundus photographs (CFPs), UWF FA, and SS-WF OCTA at baseline (M0) and 1 month after the third anti-VEGF injection (M3). All images were aligned and divided into 16 boxes for analysis of NP areas by 2 blinded retina specialists. Main Outcome Measures: The number of discrepancies between SS-WF OCTA and UWF FA regarding the detection of NP areas and small vessels passing through NP areas; assessment of DR severity on UWF CFP; and change in each NP area between M0 and M3: number of boxes/eye with presence of at least 1 NP area, number of arterioles or venules that disappeared or reappeared, and number of NP areas in which capillaries disappeared or reappeared. Results: The diabetic retinopathy (DR) severity score improved by at least 1 stage in 8 of 10 eyes, with a significant decrease in the mean number of microaneurysms and retinal hemorrhages on UWF CFP at M3 versus M0 (n = 40 +/- 28 vs. 121 +/- 57; P = 0.0020) and regression of fundus neovascularization when present. All NP areas detected on FA were seen on SS-WF OCTA, but additional NP areas were detected on SS-WF OCTA at M0 in 29% (46/160) of boxes. No reperfusion of arterioles or venules was observed at M3 on FA or SS-WF OCTA. Retinal capillaries were only visible on OCTA, and no reperfusion in NP areas was observed even when a reduction in dark areas was visible on FA. Conclusions: No reperfusion of vessels or capillary network was detected in NP areas using 2 imaging techniques, UWF FA and SS-WF OCTA, in eyes with DR after 3 anti-VEGF injections. The detection rate of NP areas was higher with SS-WF OCTA than with UWF FA. (C) 2019 by the American Academy of Ophthalmology
引用
收藏
页码:1685 / 1694
页数:10
相关论文
共 50 条
  • [31] RETINAL NONPERFUSION IN THE EARLY TREATMENT DIABETIC RETINOPATHY STUDY SEVEN FIELDS COMPARED WITH WIDEFIELD FLUORESCEIN ANGIOGRAPHY Correlation and Use of Extrapolation Factor
    Martin-Gutierrez, Maria P.
    Vermeirsch, Sandra
    Chandra, Shruti
    Agarwal, Aditi A. K.
    Selvam, Senthil
    Thottarath, Sridevi
    Vazquez-Alfageme, Clara
    Sen, Piyali
    Sivaprasad, Sobha
    Hykin, Philip G.
    Nicholson, Luke
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (08): : 1592 - 1598
  • [32] Correlation of Retinal Nonperfusion on Ultrawide Field Fluorescein Angiography to Retinopathy Severity and Macular Edema in Diabetic Eyes
    Salongcay, Recivall
    Aquino, Lizzie Anne
    Salva, Claude Michael
    Peto, Tunde
    Silva, Paolo S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [33] Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factor: Considerations Related to Nonimprovers
    Hodzic-Hadzibegovic, Delila
    Sander, Birgit Agnes
    Valerius, Marianne
    Lund-Andersen, Henrik
    OPHTHALMOLOGY RETINA, 2018, 2 (11): : 1133 - 1142
  • [34] OCT-Angiography Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Dexamethasone Implant
    Carnota-Mendez, Pablo
    Mendez-Vazquez, Carlos
    Perez-Gavela, Conchi
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 247 - 263
  • [35] Hemodynamic retinal changes in diabetic macular edema after anti-vascular endothelial growth factor injection on optical coherence tomography angiography
    Konopek, Nicholas
    Nesper, Peter L.
    Fawzi, Amani A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [36] Optical coherence tomography angiography analysis of changes in the foveal avascular zone in eyes with diabetic macular edema treated with intravitreal anti-vascular endothelial growth factor
    Albert John Bromeo
    Patricia Grulla-Quilendrino
    Ruth Camille Antolin
    Emil Joshua John Salcedo
    Cheryl A. Arcinue
    Ralph Anthony De Jesus
    Amadeo Veloso
    International Journal of Retina and Vitreous, 8
  • [37] Optical coherence tomography angiography analysis of changes in the foveal avascular zone in eyes with diabetic macular edema treated with intravitreal anti-vascular endothelial growth factor
    Bromeo, Albert John
    Grulla-Quilendrino, Patricia
    Antolin, Ruth Camille
    Salcedo, Emil Joshua John
    Arcinue, Cheryl A.
    De Jesus, Ralph Anthony
    Veloso, Amadeo, Jr.
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2022, 8 (01)
  • [38] Quantification of Retinal Nonperfusion Associated With Posterior Segment Neovascularization in Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography
    Baxter, Sally L.
    Ashir, Aria
    Nguyen, Brian J.
    Nudleman, Eric
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2019, 50 (02): : 86 - 92
  • [39] DIABETIC RETINOPATHY PATIENTS AT INITIATION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION
    Althoff, A.
    Rasouliyan, L.
    Kumar, V
    Chang, S.
    Long, S.
    VALUE IN HEALTH, 2023, 26 (06) : S257 - S257
  • [40] Anti-Vascular Endothelial Growth Factor Drugs to Reduce Diabetic Retinopathy Progression
    Schachat, Andrew P.
    Zarbin, Marco A.
    OPHTHALMOLOGY RETINA, 2018, 2 (10): : 985 - 987